"Dopaminergic Neurons" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neurons whose primary neurotransmitter is DOPAMINE.
Descriptor ID |
D059290
|
MeSH Number(s) |
A08.675.278 A11.671.270
|
Concept/Terms |
Dopaminergic Neurons- Dopaminergic Neurons
- Dopaminergic Neuron
- Neuron, Dopaminergic
- Neurons, Dopaminergic
- Dopamine Neurons
- Dopamine Neuron
- Neuron, Dopamine
- Neurons, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Dopaminergic Neurons".
Below are MeSH descriptors whose meaning is more specific than "Dopaminergic Neurons".
This graph shows the total number of publications written about "Dopaminergic Neurons" by people in this website by year, and whether "Dopaminergic Neurons" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2012 | 2 | 1 | 3 |
2013 | 0 | 1 | 1 |
2014 | 3 | 0 | 3 |
2016 | 4 | 1 | 5 |
2017 | 3 | 0 | 3 |
2018 | 1 | 1 | 2 |
2019 | 3 | 1 | 4 |
2020 | 2 | 2 | 4 |
2021 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopaminergic Neurons" by people in Profiles.
-
Treadmill exercise reduces a-synuclein spreading via PPARa. Cell Rep. 2022 07 12; 40(2):111058.
-
Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARa-Dependent Astrocytic GDNF Pathway. J Neurosci. 2021 03 10; 41(10):2287-2300.
-
Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in?vivo. Stem Cells Transl Med. 2021 02; 10(2):278-290.
-
Shared Causal Paths underlying Alzheimer's dementia and Type 2 Diabetes. Sci Rep. 2020 03 05; 10(1):4107.
-
Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease? J Parkinsons Dis. 2020; 10(2):405-411.
-
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. J Parkinsons Dis. 2020; 10(3):875-891.
-
Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain. 2019 11 01; 142(11):3565-3579.
-
RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease. Neurobiol Dis. 2019 12; 132:104575.
-
Temporal evolution of microglia and a-synuclein accumulation following foetal grafting in Parkinson's disease. Brain. 2019 06 01; 142(6):1690-1700.
-
Activation of Peroxisome Proliferator-Activated Receptor-a Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons. Mol Neurobiol. 2019 Nov; 56(11):7872-7887.